Jennifer H McQuiston, Richard Luce, Dieudonne Mwamba Kazadi, Christian Ngandu Bwangandu, Placide Mbala-Kingebeni, Mark Anderson, Joanna M Prasher, Ian T Williams, Amelia Phan, Victoria Shelus, Anna Bratcher, Gnakub Norbert Soke, Peter N Fonjungo, Joelle Kabamba, Andrea M McCollum, Robert Perry, Agam K Rao, Jeff Doty, Bryan Christensen, James A Fuller, Nicolle Baird, Jasmine Chaitram, Christopher K Brown, Amy E Kirby, David Fitter, Jennifer M Folster, Mushtaq Dualeh, Regan Hartman, Stephen M Bart, Christine M Hughes, Yoshinori Nakazawa, Emily Sims, Athalia Christie, Christina L Hutson
{"title":"U.S. Preparedness and Response to Increasing Clade I Mpox Cases in the Democratic Republic of the Congo - United States, 2024.","authors":"Jennifer H McQuiston, Richard Luce, Dieudonne Mwamba Kazadi, Christian Ngandu Bwangandu, Placide Mbala-Kingebeni, Mark Anderson, Joanna M Prasher, Ian T Williams, Amelia Phan, Victoria Shelus, Anna Bratcher, Gnakub Norbert Soke, Peter N Fonjungo, Joelle Kabamba, Andrea M McCollum, Robert Perry, Agam K Rao, Jeff Doty, Bryan Christensen, James A Fuller, Nicolle Baird, Jasmine Chaitram, Christopher K Brown, Amy E Kirby, David Fitter, Jennifer M Folster, Mushtaq Dualeh, Regan Hartman, Stephen M Bart, Christine M Hughes, Yoshinori Nakazawa, Emily Sims, Athalia Christie, Christina L Hutson","doi":"10.15585/mmwr.mm7319a3","DOIUrl":null,"url":null,"abstract":"<p><p>Clade I monkeypox virus (MPXV), which can cause severe illness in more people than clade II MPXVs, is endemic in the Democratic Republic of the Congo (DRC), but the country has experienced an increase in suspected cases during 2023-2024. In light of the 2022 global outbreak of clade II mpox, the increase in suspected clade I cases in DRC raises concerns that the virus could spread to other countries and underscores the importance of coordinated, urgent global action to support DRC's efforts to contain the virus. To date, no cases of clade I mpox have been detected outside of countries in Central Africa where the virus is endemic. CDC and other partners are working to support DRC's response. In addition, CDC is enhancing U.S. preparedness by raising awareness, strengthening surveillance, expanding diagnostic testing capacity for clade I MPXV, ensuring appropriate specimen handling and waste management, emphasizing the importance of appropriate medical treatment, and communicating guidance on the recommended contact tracing, containment, behavior modification, and vaccination strategies.</p>","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 19","pages":"435-440"},"PeriodicalIF":25.4000,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11115432/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MMWR. Morbidity and mortality weekly report","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15585/mmwr.mm7319a3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Clade I monkeypox virus (MPXV), which can cause severe illness in more people than clade II MPXVs, is endemic in the Democratic Republic of the Congo (DRC), but the country has experienced an increase in suspected cases during 2023-2024. In light of the 2022 global outbreak of clade II mpox, the increase in suspected clade I cases in DRC raises concerns that the virus could spread to other countries and underscores the importance of coordinated, urgent global action to support DRC's efforts to contain the virus. To date, no cases of clade I mpox have been detected outside of countries in Central Africa where the virus is endemic. CDC and other partners are working to support DRC's response. In addition, CDC is enhancing U.S. preparedness by raising awareness, strengthening surveillance, expanding diagnostic testing capacity for clade I MPXV, ensuring appropriate specimen handling and waste management, emphasizing the importance of appropriate medical treatment, and communicating guidance on the recommended contact tracing, containment, behavior modification, and vaccination strategies.
Ⅰ支系猴痘病毒(MPXV)比Ⅱ支系猴痘病毒可导致更多的人患上严重疾病,在刚果民主共和国(刚果(金))流行,但该国的疑似病例在2023-2024年间有所增加。鉴于 2022 年全球爆发了第二支系 mpox,刚果(金)第一支系疑似病例的增加引发了人们对该病毒可能传播到其他国家的担忧,并强调了全球采取协调、紧急行动支持刚果(金)遏制该病毒的重要性。迄今为止,在该病毒流行的中非国家之外,尚未发现 I 型 mpox 病例。疾病预防控制中心和其他合作伙伴正在努力支持刚果民主共和国的应对行动。此外,美国疾病预防控制中心正在通过提高意识、加强监测、扩大 I 支天花病毒的诊断检测能力、确保适当的标本处理和废物管理、强调适当医疗的重要性,以及传达有关建议的接触追踪、遏制、行为改变和疫苗接种策略的指导意见,加强美国的防备工作。
期刊介绍:
The Morbidity and Mortality Weekly Report (MMWR ) series is prepared by the Centers for Disease Control and Prevention (CDC).
Often called “the voice of CDC,” the MMWR series is the agency’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations.
MMWR readership predominantly consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.